{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:09:46Z","timestamp":1790888986273,"version":"4.1.0"},"reference-count":227,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Fund of the National Natural Science Foundation of China","award":["32500684"],"award-info":[{"award-number":["32500684"]}]},{"name":"the Fund of the National Natural Science Foundation of China","award":["82503802"],"award-info":[{"award-number":["82503802"]}]},{"name":"the Postdoctor Project of Hubei Province","award":["2024HBBHCXA057"],"award-info":[{"award-number":["2024HBBHCXA057"]}]},{"name":"the Postdoctor Project of Hubei Province","award":["2024HBBHJD085"],"award-info":[{"award-number":["2024HBBHJD085"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024M762472"],"award-info":[{"award-number":["2024M762472"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024M762502"],"award-info":[{"award-number":["2024M762502"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Postdoctoral Fellowship Program (Grade C) of China Postdoctoral Science Foundation","award":["GZC20231984"],"award-info":[{"award-number":["GZC20231984"]}]},{"name":"medical Sci-Tech innovation platform of Zhongnan Hospital of Wuhan University","award":["PTXM2025009"],"award-info":[{"award-number":["PTXM2025009"]}]},{"name":"the Program of Excellent Doctor of Zhongnan Hospital of Wuhan University","award":["ZNYB20240008"],"award-info":[{"award-number":["ZNYB20240008"]}]},{"name":"Engineering construction project of improving diagnosis and treatment ability of difficult diseases","award":["ZLYNXM202012"],"award-info":[{"award-number":["ZLYNXM202012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Therapeutic resistance and recurrent metastasis continue to pose major obstacles in the treatment of malignant tumors worldwide. Immunogenic cell death (ICD), characterized by its ability to both eliminate cancer cells and stimulate antitumor immune responses, has emerged as a promising strategy in the field of cancer immunotherapy. As key subtypes of ICD, pyroptosis and necroptosis contribute significantly to remodeling the tumor microenvironment (TME) and modulating immune responses through their distinct death-immunity coupling mechanisms. Characterized by plasma membrane pore formation and subsequent release of cytoplasmic contents, pyroptosis and necroptosis reprogram the immune microenvironment, thereby laying the groundwork for enhanced antitumor immune responses. Paradoxically, the chronic activation of pyroptosis and necroptosis pathways may contribute to cancer progression. Sustained inflammation within the TME promotes the release of pro-angiogenic and immunosuppressive factors, driving myeloid-derived suppressor cells (MDSCs) recruitment, extracellular matrix remodeling, and metastatic niche formation, thereby facilitating tumorigenesis and metastasis. The context-dependent dual roles of pyroptosis and necroptosis\u2014shaped by tumor histotype, chronic inflammation, and stromal context\u2014highlight the need for a nuanced understanding of their tumor-specific functions across cancer types. This review outlines the underlying mechanisms of pyroptosis and necroptosis, and summarizes recent advances, aiming to inform and inspire novel strategies in overcoming cancer immunotherapy resistance.<\/jats:p>","DOI":"10.1186\/s13046-025-03569-3","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T07:11:50Z","timestamp":1763622710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cracking the code of cancer immunotherapy resistance: emerging roles of pyroptosis and necroptosis"],"prefix":"10.1186","volume":"44","author":[{"given":"Kunming","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiujiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yige","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghai","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"3","key":"3569_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"3569_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/mco2.100","volume":"2","author":"M Liu","year":"2021","unstructured":"Liu M, Yang J, Xu B, Zhang X. Tumor metastasis: mechanistic insights and therapeutic interventions. MedComm. 2021;2(4):587\u2013617.","journal-title":"MedComm"},{"issue":"1","key":"3569_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"G Kroemer","year":"2013","unstructured":"Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013;31(1):51\u201372.","journal-title":"Annu Rev Immunol"},{"key":"3569_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00168","volume":"10","author":"P Bonaventura","year":"2019","unstructured":"Bonaventura P, Shekarian T, Alcazer V, Valladeau-Guilemond J, Valsesia-Wittmann S, Amigorena S, et al. Cold tumors: a therapeutic challenge for immunotherapy. Front Immunol. 2019;10:168.","journal-title":"Front Immunol"},{"issue":"9","key":"3569_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.693","volume":"5","author":"S Wang","year":"2024","unstructured":"Wang S, Guo S, Guo J, Du Q, Wu C, Wu Y, et al. Cell death pathways: molecular mechanisms and therapeutic targets for cancer. MedComm. 2024;5(9):e693.","journal-title":"MedComm"},{"issue":"1","key":"3569_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000337","volume":"8","author":"L Galluzzi","year":"2020","unstructured":"Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J Immunother Cancer. 2020;8(1):e000337.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"3569_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0966-842X(00)01936-3","volume":"9","author":"BT Cookson","year":"2001","unstructured":"Cookson BT, Brennan MA. Pro-inflammatory programmed cell death. Trends Microbiol. 2001;9(3):113\u20134.","journal-title":"Trends Microbiol"},{"issue":"12","key":"3569_CR8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","volume":"25","author":"W ting He","year":"2015","unstructured":"ting He W, Wan H, Hu L, Chen P, Wang X, Huang Z, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion. Cell Res. 2015;25(12):1285\u201398.","journal-title":"Cell Res"},{"issue":"1","key":"3569_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6(1):128.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"3569_CR10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/cr.2016.100","volume":"26","author":"X Chen","year":"2016","unstructured":"Chen X, He WT, Hu L, Li J, Fang Y, Wang X, et al. Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res. 2016;26(9):1007\u201320.","journal-title":"Cell Res"},{"issue":"7","key":"3569_CR11","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.cell.2008.10.044","volume":"135","author":"J Hitomi","year":"2008","unstructured":"Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell. 2008;135(7):1311\u201323.","journal-title":"Cell"},{"issue":"7","key":"3569_CR12","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.cell.2008.12.004","volume":"135","author":"L Galluzzi","year":"2008","unstructured":"Galluzzi L, Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell. 2008;135(7):1161\u20133.","journal-title":"Cell"},{"issue":"1\u20132","key":"3569_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun L, Wang H, Wang Z, He S, Chen S, Liao D, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 2012;148(1\u20132):213\u201327.","journal-title":"Cell"},{"issue":"5","key":"3569_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/cr.2016.26","volume":"26","author":"B Xia","year":"2016","unstructured":"Xia B, Fang S, Chen X, Hu H, Chen P, Wang H, et al. MLKL forms cation channels. Cell Res. 2016;26(5):517\u201328.","journal-title":"Cell Res"},{"issue":"5","key":"3569_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1631\/jzus.B1900160","volume":"20","author":"F Zhu","year":"2019","unstructured":"Zhu F, Zhang W, Yang T, He SD. Complex roles of necroptosis in cancer. J Zhejiang Univ Sci B. 2019;20(5):399\u2013413.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"19","key":"3569_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910760","volume":"25","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zhang F, Xie W, Niu Y, Wang H, Li G, et al. Induced necroptosis and its role in cancer immunotherapy. Int J Mol Sci. 2024;25(19):10760.","journal-title":"Int J Mol Sci"},{"key":"3569_CR17","doi-asserted-by":"crossref","unstructured":"Bai R, Chen N, Li L, Du N, Bai L, Lv Z, et al. Mechanisms of cancer resistance to immunotherapy. Front Oncol. 2020;10:01290.","DOI":"10.3389\/fonc.2020.01290"},{"key":"3569_CR18","doi-asserted-by":"crossref","unstructured":"Zhou B, Gao Y, Zhang P, Chu Q. Acquired resistance to immune checkpoint blockades: the underlying mechanisms and potential strategies. Front Immunol. 2021;12:693609.","DOI":"10.3389\/fimmu.2021.693609"},{"issue":"5","key":"3569_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.trecan.2023.02.001","volume":"9","author":"K H\u00e4nggi","year":"2023","unstructured":"H\u00e4nggi K, Ruffell B. Cell death, therapeutics, and the immune response in cancer. Trends Cancer. 2023;9(5):381\u201396.","journal-title":"Trends Cancer"},{"issue":"1","key":"3569_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010169","volume":"11","author":"A Parab","year":"2023","unstructured":"Parab A, Kumar Bhatt L, Omri A. Targeting epigenetic mechanisms: a boon for cancer immunotherapy. Biomedicines. 2023;11(1):169.","journal-title":"Biomedicines"},{"issue":"19","key":"3569_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194783","volume":"20","author":"C Riganti","year":"2019","unstructured":"Riganti C, Contino M. New strategies to overcome resistance to chemotherapy and immune system in cancer. Int J Mol Sci. 2019;20(19):4783.","journal-title":"Int J Mol Sci"},{"key":"3569_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.semcdb.2015.02.002","volume":"39","author":"MC de Almagro","year":"2015","unstructured":"de Almagro MC, Vucic D, Necroptosis. Pathway diversity and characteristics. Semin Cell Dev Biol. 2015;39:56\u201362.","journal-title":"Semin Cell Dev Biol"},{"key":"3569_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112082","volume":"142","author":"Q Wang","year":"2021","unstructured":"Wang Q, Fan D, Xia Y, Ye Q, Xi X, Zhang G, et al. The latest information on the RIPK1 post-translational modifications and functions. Biomed Pharmacother. 2021;142:112082.","journal-title":"Biomed Pharmacother"},{"issue":"43","key":"3569_CR24","doi-asserted-by":"publisher","first-page":"31268","DOI":"10.1074\/jbc.M113.462341","volume":"288","author":"WJ Kaiser","year":"2013","unstructured":"Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem. 2013;288(43):31268\u201379.","journal-title":"J Biol Chem"},{"key":"3569_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102347","volume":"83","author":"C DeAntoneo","year":"2023","unstructured":"DeAntoneo C, Herbert A, Balachandran S. Z-form nucleic acid-binding protein 1 (ZBP1) as a sensor of viral and cellular Z-RNAs: walking the razor\u2019s edge. Curr Opin Immunol. 2023;83:102347.","journal-title":"Curr Opin Immunol"},{"key":"3569_CR26","doi-asserted-by":"crossref","unstructured":"Kawasaki T, Kawai T. Toll-Like receptor signaling pathways. Front Immunol. 2014;5.","DOI":"10.3389\/fimmu.2014.00461"},{"issue":"3","key":"3569_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.chom.2012.01.016","volume":"11","author":"JW Upton","year":"2012","unstructured":"Upton JW, Kaiser WJ, Mocarski ES. DAI\/ZBP1\/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe. 2012;11(3):290\u20137.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"3569_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23004-3","volume":"12","author":"JY Baik","year":"2021","unstructured":"Baik JY, Liu Z, Jiao D, Kwon HJ, Yan J, Kadigamuwa C, et al. ZBP1 not RIPK1 mediates tumor necroptosis in breast cancer. Nat Commun. 2021;12(1):2666.","journal-title":"Nat Commun"},{"issue":"4","key":"3569_CR29","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1042\/BST20220535","volume":"50","author":"T Riebeling","year":"2022","unstructured":"Riebeling T, Kunzendorf U, Krautwald S. The role of RHIM in necroptosis. Biochem Soc Trans. 2022;50(4):1197\u2013205.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"3569_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trecan.2021.09.003","volume":"8","author":"J Yan","year":"2022","unstructured":"Yan J, Wan P, Choksi S, Liu ZG. Necroptosis and tumor progression. Trends Cancer. 2022;8(1):21\u20137.","journal-title":"Trends Cancer"},{"issue":"1","key":"3569_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41590-024-02024-3","volume":"26","author":"CL Holley","year":"2025","unstructured":"Holley CL, Monteleone M, Fisch D, Libert AES, Ju RJ, Choi JH, et al. Pyroptotic cell corpses are crowned with F-actin-rich filopodia that engage CLEC9A signaling in incoming dendritic cells. Nat Immunol. 2025;26(1):42\u201352.","journal-title":"Nat Immunol"},{"issue":"1","key":"3569_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.coi.2012.12.007","volume":"25","author":"D Sancho","year":"2013","unstructured":"Sancho D, Reis e Sousa C. Sensing of cell death by myeloid C-type lectin receptors. Curr Opin Immunol. 2013;25(1):46\u201352.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"3569_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41421-019-0108-8","volume":"5","author":"J Lu","year":"2019","unstructured":"Lu J, Shi W, Liang B, Chen C, Wu R, Lin H, et al. Efficient engulfment of necroptotic and pyroptotic cells by nonprofessional and professional phagocytes. Cell Discov. 2019;5(1):1\u20135.","journal-title":"Cell Discov"},{"issue":"6258","key":"3569_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.aad0395","volume":"350","author":"N Yatim","year":"2015","unstructured":"Yatim N, Jusforgues-Saklani H, Orozco S, Schulz O, Barreira da Silva R, Reis e Sousa C, et al. RIPK1 and NF-\u03baB signaling in dying cells determines cross-priming of CD8+ T cells. Science. 2015;350(6258):328\u201334.","journal-title":"Science"},{"issue":"5","key":"3569_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.129","volume":"6","author":"N Werthm\u00f6ller","year":"2015","unstructured":"Werthm\u00f6ller N, Frey B, Wunderlich R, Fietkau R, Gaipl US. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner. Cell Death Dis. 2015;6(5):e1761.","journal-title":"Cell Death Dis"},{"issue":"9","key":"3569_CR36","doi-asserted-by":"publisher","first-page":"e009552","DOI":"10.1136\/jitc-2024-009552","volume":"12","author":"FG \u00d6zbay Kurt","year":"2024","unstructured":"\u00d6zbay Kurt FG, Cicortas BA, Balzasch BM, De la Torre C, Ast V, Tavukcuoglu E, et al. S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling. J Immuno Ther Cancer. 2024;12(9):e009552.","journal-title":"J Immuno Ther Cancer"},{"issue":"7","key":"3569_CR37","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1093\/cercor\/bhy089","volume":"28","author":"J Yang","year":"2018","unstructured":"Yang J, Zhao Y, Zhang L, Fan H, Qi C, Zhang K, et al. RIPK3\/MLKL-mediated neuronal necroptosis modulates the M1\/M2 polarization of Microglia\/Macrophages in the ischemic cortex. Cereb Cortex. 2018;28(7):2622\u201335.","journal-title":"Cereb Cortex"},{"issue":"1","key":"3569_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/i8010061","volume":"45","author":"J Wang","year":"2020","unstructured":"Wang J, Li R, Peng Z, Hu B, Rao X, Li J. HMGB1 participates in LPS\u2013induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE\/NF\u2013\u03baB signaling pathways. Int J Mol Sci. 2020;45(1):61\u201380.","journal-title":"Int J Mol Sci"},{"key":"3569_CR39","doi-asserted-by":"crossref","unstructured":"Xu Z, Chen Zmo, Wu X, Zhang L, Cao Y, Zhou P. Distinct molecular mechanisms underlying potassium efflux for NLRP3 inflammasome activation. Front Immunol. 2020;11:609441.","DOI":"10.3389\/fimmu.2020.609441"},{"issue":"1","key":"3569_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1606-4","volume":"16","author":"J Chen","year":"2018","unstructured":"Chen J, Wang S, Fu R, Zhou M, Zhang T, Pan W, et al. RIP3 dependent NLRP3 inflammasome activation is implicated in acute lung injury in mice. J Transl Med. 2018;16(1):233.","journal-title":"J Transl Med"},{"key":"3569_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10555","volume":"7","author":"M Karmakar","year":"2016","unstructured":"Karmakar M, Katsnelson MA, Dubyak GR, Pearlman E. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1\u03b2 secretion in response to ATP. Nat Commun. 2016;7:10555.","journal-title":"Nat Commun"},{"issue":"12","key":"3569_CR42","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41423-023-01086-x","volume":"20","author":"MM Hu","year":"2023","unstructured":"Hu MM, Shu HB. Mitochondrial DNA-triggered innate immune response: mechanisms and diseases. Cell Mol Immunol. 2023;20(12):1403\u201312.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"3569_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.immuni.2017.07.016","volume":"47","author":"MM Xu","year":"2017","unstructured":"Xu MM, Pu Y, Han D, Shi Y, Cao X, Liang H, et al. Dendritic cells but not macrophages sense tumor mitochondrial DNA for Cross-priming through signal regulatory protein \u03b1 signaling. Immunity. 2017;47(2):363\u2013e3735.","journal-title":"Immunity"},{"issue":"1","key":"3569_CR44","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2023.12030","volume":"26","author":"X Duan","year":"2023","unstructured":"Duan X, Du H, Yuan M, Liu L, Liu R, Shi J. Bioinformatics analysis of necroptosis\u2013related LncRNAs and immune infiltration, and prediction of the prognosis of patients with esophageal carcinoma. Exp Ther Med. 2023;26(1):331.","journal-title":"Exp Ther Med"},{"issue":"11","key":"3569_CR45","doi-asserted-by":"publisher","first-page":"8635","DOI":"10.18632\/oncotarget.3249","volume":"6","author":"SV Schmidt","year":"2015","unstructured":"Schmidt SV, Seibert S, Walch-R\u00fcckheim B, Vicinus B, Kamionka EM, Pahne-Zeppenfeld J, et al. RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1\u03b1 release, and efficient paracrine dendritic cell activation. Oncotarget. 2015;6(11):8635\u201347.","journal-title":"Oncotarget"},{"issue":"29","key":"3569_CR46","doi-asserted-by":"publisher","first-page":"46384","DOI":"10.18632\/oncotarget.10135","volume":"7","author":"D Bozec","year":"2016","unstructured":"Bozec D, Iuga AC, Roda G, Dahan S, Yeretssian G. Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis. Oncotarget. 2016;7(29):46384\u2013400.","journal-title":"Oncotarget"},{"issue":"20","key":"3569_CR47","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1158\/0008-5472.CAN-13-2347","volume":"74","author":"KH Parker","year":"2014","unstructured":"Parker KH, Sinha P, Horn LA, Clements VK, Yang H, Li J, et al. Hmgb1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells. Cancer Res. 2014;74(20):5723\u201333.","journal-title":"Cancer Res"},{"issue":"7598","key":"3569_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature17403","volume":"532","author":"L Seifert","year":"2016","unstructured":"Seifert L, Werba G, Tiwari S, Giao Ly NN, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532(7598):245\u20139.","journal-title":"Nature"},{"issue":"21","key":"3569_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112714","volume":"23","author":"HS Chaouhan","year":"2022","unstructured":"Chaouhan HS, Vinod C, Mahapatra N, Yu SH, Wang IK, Chen KB, et al. Necroptosis: a pathogenic negotiator in human diseases. Int J Mol Sci. 2022;23(21):12714.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3569_CR50","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1258504","volume":"6","author":"J Zhang","year":"2017","unstructured":"Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi neutrophil-like myeloid-derived suppressor cells exert immune suppression through arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6(2):e1258504.","journal-title":"Oncoimmunology"},{"issue":"7","key":"3569_CR51","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"3569_CR52","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ni.2237","volume":"13","author":"VAK Rathinam","year":"2012","unstructured":"Rathinam VAK, Vanaja SK, Fitzgerald KA. Regulation of inflammasome signaling. Nat Immunol. 2012;13(4):333\u201342.","journal-title":"Nat Immunol"},{"key":"3569_CR53","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol. 2020;38:567\u201395.","journal-title":"Annu Rev Immunol"},{"key":"3569_CR54","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301\u201316.","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"3569_CR55","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1002\/eji.201545655","volume":"45","author":"PJ Baker","year":"2015","unstructured":"Baker PJ, Boucher D, Bierschenk D, Tebartz C, Whitney PG, D\u2019Silva DB, et al. NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5. Eur J Immunol. 2015;45(10):2918\u201326.","journal-title":"Eur J Immunol"},{"issue":"7371","key":"3569_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, et al. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479(7371):117\u201321.","journal-title":"Nature"},{"issue":"7991","key":"3569_CR57","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41586-023-06742-w","volume":"624","author":"X Shi","year":"2023","unstructured":"Shi X, Sun Q, Hou Y, Zeng H, Cao Y, Dong M, et al. Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome. Nature. 2023;624(7991):442\u201350.","journal-title":"Nature"},{"issue":"9","key":"3569_CR58","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1084\/jem.20180589","volume":"215","author":"BL Lee","year":"2018","unstructured":"Lee BL, Stowe IB, Gupta A, Kornfeld OS, Roose-Girma M, Anderson K, et al. Caspase-11 auto-proteolysis is crucial for noncanonical inflammasome activation. J Exp Med. 2018;215(9):2279\u201388.","journal-title":"J Exp Med"},{"issue":"10","key":"3569_CR59","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1002\/eji.201545772","volume":"45","author":"S R\u00fchl","year":"2015","unstructured":"R\u00fchl S, Broz P. Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux. Eur J Immunol. 2015;45(10):2927\u201336.","journal-title":"Eur J Immunol"},{"issue":"2","key":"3569_CR60","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","volume":"6","author":"AG Porter","year":"1999","unstructured":"Porter AG, J\u00e4nicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6(2):99\u2013104.","journal-title":"Cell Death Differ"},{"key":"3569_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-020-00349-0","volume":"6","author":"M Jiang","year":"2020","unstructured":"Jiang M, Qi L, Li L, Li Y. The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov. 2020;6:112.","journal-title":"Cell Death Discov"},{"issue":"1","key":"3569_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09397-2","volume":"10","author":"C Rogers","year":"2019","unstructured":"Rogers C, Erkes DA, Nardone A, Aplin AE, Fernandes-Alnemri T, Alnemri ES. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat Commun. 2019;10(1):1689.","journal-title":"Nat Commun"},{"issue":"7661","key":"3569_CR63","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547(7661):99\u2013103.","journal-title":"Nature"},{"issue":"2","key":"3569_CR64","volume":"1873","author":"R Mandal","year":"2020","unstructured":"Mandal R, Barr\u00f3n JC, Kostova I, Becker S, Strebhardt K. Caspase-8: the double-edged sword. Biochimica et Biophysica Acta (BBA). 2020;1873(2):188357.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"46","key":"3569_CR65","doi-asserted-by":"publisher","first-page":"E10888","DOI":"10.1073\/pnas.1809548115","volume":"115","author":"J Sarhan","year":"2018","unstructured":"Sarhan J, Liu BC, Muendlein HI, Li P, Nilson R, Tang AY, et al. Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during yersinia infection. Proc Natl Acad Sci U S A. 2018;115(46):E10888-97.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"3569_CR66","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41422-021-00506-9","volume":"31","author":"JY Zhang","year":"2021","unstructured":"Zhang JY, Zhou B, Sun RY, Ai YL, Cheng K, Li FN, et al. The metabolite \u03b1-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8. Cell Res. 2021;31(9):980\u201397.","journal-title":"Cell Res"},{"issue":"17","key":"3569_CR67","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.7150\/jca.48989","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Peng J, Xie X, Zhang Z, Li M, Yang M. Gasdermin E-mediated programmed cell death: an unpaved path to tumor suppression. J Cancer. 2021;12(17):5241\u20138.","journal-title":"J Cancer"},{"issue":"82","key":"3569_CR68","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg3196","volume":"8","author":"Q Kong","year":"2023","unstructured":"Kong Q, Xia S, Pan X, Ye K, Li Z, Li H, et al. Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis. Sci Immunol. 2023;8(82):eadg3196.","journal-title":"Sci Immunol"},{"issue":"3","key":"3569_CR69","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.cell.2023.12.015","volume":"187","author":"Z Li","year":"2024","unstructured":"Li Z, Ma R, Tang H, Guo J, Shah Z, Zhang J, et al. Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death. Cell. 2024;187(3):624\u2013e64123.","journal-title":"Cell"},{"issue":"6494","key":"3569_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz7548","volume":"368","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, He H, Wang K, Shi X, Wang Y, Su Y, et al. Granzyme a from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020;368(6494):eaaz7548.","journal-title":"Science"},{"issue":"9","key":"3569_CR71","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","volume":"19","author":"X Wei","year":"2022","unstructured":"Wei X, Xie F, Zhou X, Wu Y, Yan H, Liu T, et al. Role of pyroptosis in inflammation and cancer. Cell Mol Immunol. 2022;19(9):971\u201392.","journal-title":"Cell Mol Immunol"},{"issue":"22","key":"3569_CR72","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1016\/j.molcel.2021.09.003","volume":"81","author":"J Hou","year":"2021","unstructured":"Hou J, Hsu JM, Hung MC. Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity. Mol Cell. 2021;81(22):4579\u201390.","journal-title":"Mol Cell"},{"issue":"6","key":"3569_CR73","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1016\/j.gendis.2022.04.019","volume":"10","author":"W Liu","year":"2023","unstructured":"Liu W, Peng J, Xiao M, Cai Y, Peng B, Zhang W, et al. The implication of pyroptosis in cancer immunology: current advances and prospects. Genes Dis. 2023;10(6):2339\u201350.","journal-title":"Genes Dis"},{"issue":"1","key":"3569_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04187-3","volume":"21","author":"WQ Feng","year":"2023","unstructured":"Feng WQ, Zhang YC, Xu ZQ, Yu SY, Huo JT, Tuersun A, et al. IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8\u2009+\u2009t-cell tumour infiltration. J Transl Med. 2023;21(1):335.","journal-title":"J Transl Med"},{"key":"3569_CR75","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbrc.2021.02.043","volume":"548","author":"J Guo","year":"2021","unstructured":"Guo J, Zheng J, Mu M, Chen Z, Xu Z, Zhao C, et al. GW4064 enhances the chemosensitivity of colorectal cancer to oxaliplatin by inducing pyroptosis. Biochem Biophys Res Commun. 2021;548:60\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"3569_CR76","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","volume":"43","author":"RC Coll","year":"2022","unstructured":"Coll RC, Schroder K, Pelegr\u00edn P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci. 2022;43(8):653\u201368.","journal-title":"Trends Pharmacol Sci"},{"issue":"19","key":"3569_CR77","doi-asserted-by":"publisher","first-page":"5586","DOI":"10.1158\/0008-5472.CAN-17-3962","volume":"78","author":"G Yan","year":"2018","unstructured":"Yan G, Zhao H, Zhang Q, Zhou Y, Wu L, Lei J, et al. A RIPK3-PGE2 circuit mediates myeloid-derived suppressor cell-potentiated colorectal carcinogenesis. Cancer Res. 2018;78(19):5586\u201399.","journal-title":"Cancer Res"},{"issue":"1","key":"3569_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07436-z","volume":"16","author":"P Jiang","year":"2025","unstructured":"Jiang P, Chipurupalli S, Yoo BH, Liu X, Rosen KV. Inactivation of necroptosis-promoting protein MLKL creates a therapeutic vulnerability in colorectal cancer cells. Cell Death Dis. 2025;16(1):118.","journal-title":"Cell Death Dis"},{"key":"3569_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114477","volume":"203","author":"LC Hsieh","year":"2024","unstructured":"Hsieh LC, Le TK, Hu FC, Chen YT, Hsieh S, Wu CC, et al. Targeted colorectal cancer treatment: In vitro anti-cancer effects of carnosine nanoparticles supported by agar and magnetic iron oxide. Eur J Pharm Biopharm. 2024;203:114477.","journal-title":"Eur J Pharm Biopharm"},{"issue":"23","key":"3569_CR80","doi-asserted-by":"publisher","first-page":"e2300548","DOI":"10.1002\/adma.202300548","volume":"35","author":"X Li","year":"2023","unstructured":"Li X, Duan Z, Chen X, Pan D, Luo Q, Gu L, et al. Impairing tumor metabolic plasticity via a stable Metal-Phenolic-Based polymeric nanomedicine to suppress colorectal cancer. Adv Mater. 2023;35(23):e2300548.","journal-title":"Adv Mater"},{"issue":"1","key":"3569_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05524-y","volume":"14","author":"P Lin","year":"2023","unstructured":"Lin P, Lin C, He R, Chen H, Teng Z, Yao H, et al. TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1\/RIPK3\/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer. Cell Death Dis. 2023;14(1):6.","journal-title":"Cell Death Dis"},{"issue":"15","key":"3569_CR82","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3748\/wjg.v30.i15.2155","volume":"30","author":"N Wang","year":"2024","unstructured":"Wang N, Li CY, Yao TF, Kang XD, Guo HS. Osw-1 triggers necroptosis in colorectal cancer cells through the RIPK1\/RIPK3\/MLKL signaling pathway facilitated by the RIPK1-p62\/SQSTM1 complex. World J Gastroenterol. 2024;30(15):2155\u201374.","journal-title":"World J Gastroenterol"},{"issue":"15","key":"3569_CR83","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.3390\/ijms23158464","volume":"23","author":"NA Cacciola","year":"2022","unstructured":"Cacciola NA, Salzano A, D\u2019Onofrio N, Venneri T, Cicco PD, Vinale F, et al. Buffalo milk Whey activates necroptosis and apoptosis in a xenograft model of colorectal cancer. Int J Mol Sci. 2022;23(15):8464.","journal-title":"Int J Mol Sci"},{"key":"3569_CR84","doi-asserted-by":"publisher","first-page":"114690","DOI":"10.1016\/j.jep.2021.114690","volume":"283","author":"X Wu","year":"2022","unstructured":"Wu X, Lu Y, Qin X. Ction and cisplatin shows synergistic antitumor activity in p53-R273H\/P309S mutant colorectal cancer cells through inducing apoptosis. J Ethnopharmacol. 2022;283:114690.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"3569_CR85","doi-asserted-by":"publisher","DOI":"10.4081\/ejh.2021.3247","volume":"65","author":"S Wu","year":"2021","unstructured":"Wu S, Zhou Y, Liu P, Zhang H, Wang W, Fang Y, et al. Microrna-29b-3p promotes 5-fluorouracil resistance via suppressing TRAF5-mediated necroptosis in human colorectal cancer. Eur J Histochem. 2021;65(2):3247.","journal-title":"Eur J Histochem"},{"issue":"7799","key":"3569_CR86","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41586-020-2079-1","volume":"579","author":"Q Wang","year":"2020","unstructured":"Wang Q, Wang Y, Ding J, Wang C, Zhou X, Gao W, et al. A bioorthogonal system reveals antitumour immune function of pyroptosis. Nature. 2020;579(7799):421\u20136.","journal-title":"Nature"},{"issue":"5","key":"3569_CR87","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1084\/jem.20100050","volume":"207","author":"IC Allen","year":"2010","unstructured":"Allen IC, TeKippe EM, Woodford RMT, Uronis JM, Holl EK, Rogers AB, et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med. 2010;207(5):1045\u201356.","journal-title":"J Exp Med"},{"issue":"21","key":"3569_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111640","volume":"25","author":"T Maeda","year":"2024","unstructured":"Maeda T, Shirakami Y, Taguchi D, Miwa T, Kubota M, Sakai H, et al. Glyburide suppresses inflammation-related colorectal tumorigenesis through inhibition of NLRP3 inflammasome. Int J Mol Sci. 2024;25(21):11640.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3569_CR89","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/mi.2012.8","volume":"5","author":"FA Carvalho","year":"2012","unstructured":"Carvalho FA, Nalbantoglu I, Aitken JD, Uchiyama R, Su Y, Doho GH, et al. Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges. Mucosal Immunol. 2012;5(3):288\u201398.","journal-title":"Mucosal Immunol"},{"issue":"4","key":"3569_CR90","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","volume":"19","author":"R Karki","year":"2019","unstructured":"Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer. 2019;19(4):197\u2013214.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3569_CR91","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tcb.2022.06.006","volume":"33","author":"AI Ivanov","year":"2023","unstructured":"Ivanov AI, Rana N, Privitera G, Pizarro TT. The enigmatic roles of epithelial gasdermin B: recent discoveries and controversies. Trends Cell Biol. 2023;33(1):48\u201359.","journal-title":"Trends Cell Biol"},{"issue":"10","key":"3569_CR92","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1038\/s41401-022-00887-6","volume":"43","author":"F Yang","year":"2022","unstructured":"Yang F, Bettadapura SN, Smeltzer MS, Zhu H, Wang S. Pyroptosis and pyroptosis-inducing cancer drugs. Acta Pharmacol Sin. 2022;43(10):2462\u201373.","journal-title":"Acta Pharmacol Sin"},{"key":"3569_CR93","doi-asserted-by":"publisher","first-page":"10397","DOI":"10.2147\/CMAR.S244374","volume":"12","author":"LS Wu","year":"2020","unstructured":"Wu LS, Liu Y, Wang XW, Xu B, Lin YL, Song Y, et al. LPS enhances the chemosensitivity of oxaliplatin in HT29 cells via GSDMD-Mediated pyroptosis. Cancer Manag Res. 2020;12:10397\u2013409.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"3569_CR94","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2333790","volume":"16","author":"N Wang","year":"2024","unstructured":"Wang N, Zhang L, Leng XX, Xie YL, Kang ZR, Zhao LC, et al. Fusobacterium nucleatum induces chemoresistance in colorectal cancer by inhibiting pyroptosis via the Hippo pathway. Gut Microbes. 2024;16(1):2333790.","journal-title":"Gut Microbes"},{"issue":"26","key":"3569_CR95","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509\u201320.","journal-title":"N Engl J Med"},{"issue":"39","key":"3569_CR96","doi-asserted-by":"publisher","first-page":"18570","DOI":"10.1039\/D4NR01497A","volume":"16","author":"F Cheng","year":"2024","unstructured":"Cheng F, He L, Wang J, Lai L, Ma L, Qu K, et al. Synergistic immunotherapy with a calcium-based nanoinducer: evoking pyroptosis and remodeling tumor-associated macrophages for enhanced antitumor immune response. Nanoscale. 2024;16(39):18570\u201383.","journal-title":"Nanoscale"},{"issue":"6","key":"3569_CR97","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1053\/j.gastro.2012.12.042","volume":"144","author":"L Zheng","year":"2013","unstructured":"Zheng L, Xue J, Jaffee EM, Habtezion A. Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma. Gastroenterology. 2013;144(6):1230\u201340.","journal-title":"Gastroenterology"},{"issue":"16","key":"3569_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612633","volume":"24","author":"V Giansante","year":"2023","unstructured":"Giansante V, Stati G, Sancilio S, Guerra E, Alberti S, Di Pietro R. The dual role of necroptosis in pancreatic ductal adenocarcinoma. Int J Mol Sci. 2023;24(16):12633.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3569_CR99","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1158\/2159-8290.CD-15-1346","volume":"6","author":"MM Kaneda","year":"2016","unstructured":"Kaneda MM, Cappello P, Nguyen AV, Ralainirina N, Hardamon CR, Foubert P, et al. Macrophage PI3K\u03b3 drives pancreatic ductal adenocarcinoma progression. Cancer Discov. 2016;6(8):870\u201385.","journal-title":"Cancer Discov"},{"issue":"1","key":"3569_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50450-6","volume":"15","author":"CY Liao","year":"2024","unstructured":"Liao CY, Li G, Kang FP, Lin CF, Xie CK, Wu YD, et al. Necroptosis enhances don\u2019t eat me signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis. Nat Commun. 2024;15(1):6043.","journal-title":"Nat Commun"},{"issue":"5","key":"3569_CR101","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ccell.2018.10.006","volume":"34","author":"W Wang","year":"2018","unstructured":"Wang W, Marinis JM, Beal AM, Savadkar S, Wu Y, Khan M, et al. RIP1 kinase drives Macrophage-Mediated adaptive immune tolerance in pancreatic cancer. Cancer Cell. 2018;34(5):757\u2013e7747.","journal-title":"Cancer Cell"},{"issue":"6","key":"3569_CR102","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1158\/1078-0432.CCR-17-2283","volume":"24","author":"AD Michaels","year":"2018","unstructured":"Michaels AD, Newhook TE, Adair SJ, Morioka S, Goudreau BJ, Nagdas S, et al. CD47 blockade as an adjuvant immunotherapy for resectable pancreatic cancer. Clin Cancer Res. 2018;24(6):1415\u201325.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3569_CR103","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000253","volume":"8","author":"Q Xi","year":"2020","unstructured":"Xi Q, Zhang J, Yang G, Zhang L, Chen Y, Wang C, et al. Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity. J Immunother Cancer. 2020;8(1):e000253.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"3569_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04014-x","volume":"12","author":"S Hannes","year":"2021","unstructured":"Hannes S, Karlowitz R, Van Wijk SJL. The smac mimetic BV6 cooperates with STING to induce necroptosis in apoptosis-resistant pancreatic carcinoma cells. Cell Death Dis. 2021;12(9):816.","journal-title":"Cell Death Dis"},{"issue":"10","key":"3569_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102792","volume":"11","author":"E Barar","year":"2023","unstructured":"Barar E, Shi J. Genome, metabolism, or immunity: which is the primary decider of pancreatic cancer fate through non-apoptotic cell death? Biomedicines. 2023;11(10):2792.","journal-title":"Biomedicines"},{"issue":"1","key":"3569_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03632-z","volume":"20","author":"C Yan","year":"2022","unstructured":"Yan C, Niu Y, Li F, Zhao W, Ma L. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. J Transl Med. 2022;20(1):455.","journal-title":"J Transl Med"},{"issue":"9","key":"3569_CR107","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.7150\/thno.71086","volume":"12","author":"Z Rao","year":"2022","unstructured":"Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao C, et al. Pyroptosis in inflammatory diseases and cancer. Theranostics. 2022;12(9):4310\u201329.","journal-title":"Theranostics"},{"issue":"678","key":"3569_CR108","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl7895","volume":"15","author":"L Su","year":"2023","unstructured":"Su L, Chen Y, Huang C, Wu S, Wang X, Zhao X, et al. Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models. Sci Transl Med. 2023;15(678):eabl7895.","journal-title":"Sci Transl Med"},{"key":"3569_CR109","doi-asserted-by":"crossref","unstructured":"Yu B, Wang Y, Bing T, Tang Y, Huang J, Xiao H, et al. Platinum prodrug nanoparticles with COX-2 inhibition amplify pyroptosis for enhanced chemotherapy and immune activation of pancreatic cancer. Adv Mater. 2024;36(11):e2310456.","DOI":"10.1002\/adma.202310456"},{"issue":"1","key":"3569_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41377-025-01757-6","volume":"14","author":"Q Cheng","year":"2025","unstructured":"Cheng Q, Wang Q, Qu S. Photon-triggered pyroptosis and ferroptosis dual-functional nanoplatform for cancer immunotherapy. Light Sci Appl. 2025;14(1):104.","journal-title":"Light Sci Appl"},{"issue":"26","key":"3569_CR111","doi-asserted-by":"publisher","first-page":"17854","DOI":"10.1021\/jacs.4c03478","volume":"146","author":"X Wang","year":"2024","unstructured":"Wang X, Ding B, Liu W, Qi L, Li J, Zheng X, et al. Dual starvations induce pyroptosis for orthotopic pancreatic cancer therapy through simultaneous deprivation of glucose and glutamine. J Am Chem Soc. 2024;146(26):17854\u201365.","journal-title":"J Am Chem Soc"},{"key":"3569_CR112","doi-asserted-by":"crossref","unstructured":"Li MQ, He YQ, Zhang MN, Tang W, Tan Y, Cheng Y, et al. Dronedarone hydrochloride (DH) induces pancreatic cancer cell death by triggering mtDNA-mediated pyroptosis. Cell Death Dis. 2024;15(10):725.","DOI":"10.1038\/s41419-024-07102-w"},{"issue":"1","key":"3569_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06247-2","volume":"23","author":"Y Hu","year":"2025","unstructured":"Hu Y, Qi E, Yun C, Li X, Liu F, Cheng Z, et al. Photothermal therapy combined with a STING agonist induces pyroptosis, and gasdermin D could be a new biomarker for guiding the treatment of pancreatic cancer. J Transl Med. 2025;23(1):271.","journal-title":"J Transl Med"},{"key":"3569_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176175","volume":"961","author":"X Wang","year":"2023","unstructured":"Wang X, Chen Z, Nie D, Zeng X, Zhong M, Liu X, et al. CASP1 is a target for combination therapy in pancreatic cancer. Eur J Pharmacol. 2023;961:176175.","journal-title":"Eur J Pharmacol"},{"issue":"3\u20134","key":"3569_CR115","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s10495-023-01901-w","volume":"29","author":"G Wang","year":"2024","unstructured":"Wang G, Chen J, Dai S, Zhang J, Gao Y, Yin L, et al. High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance. Apoptosis. 2024;29(3\u20134):344\u201356.","journal-title":"Apoptosis"},{"key":"3569_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216206","volume":"564","author":"S Li","year":"2023","unstructured":"Li S, Yue M, Xu H, Zhang X, Mao T, Quan M, et al. Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer. Cancer Lett. 2023;564:216206.","journal-title":"Cancer Lett"},{"issue":"9","key":"3569_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.240","volume":"6","author":"P Geserick","year":"2015","unstructured":"Geserick P, Wang J, Schilling R, Horn S, Harris PA, Bertin J, et al. Absence of RIPK3 predicts necroptosis resistance in malignant melanoma. Cell Death Dis. 2015;6(9):e1884.","journal-title":"Cell Death Dis"},{"issue":"6","key":"3569_CR118","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/cr.2015.56","volume":"25","author":"GB Koo","year":"2015","unstructured":"Koo GB, Morgan MJ, Lee DG, Kim WJ, Yoon JH, Koo JS, et al. Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res. 2015;25(6):707\u201325.","journal-title":"Cell Res"},{"issue":"7","key":"3569_CR119","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1038\/s41418-020-0499-y","volume":"27","author":"CC Lin","year":"2020","unstructured":"Lin CC, Mabe NW, Lin YT, Yang WH, Tang X, Hong L, et al. RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence. Cell Death Differ. 2020;27(7):2234\u201347.","journal-title":"Cell Death Differ"},{"issue":"5","key":"3569_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108341","volume":"33","author":"NW Mabe","year":"2020","unstructured":"Mabe NW, Garcia NMG, Wolery SE, Newcomb R, Meingasner RC, Vilona BA. G9a promotes breast cancer recurrence through repression of a pro-inflammatory program. Cell Rep. 2020;33(5):108341.","journal-title":"Cell Rep"},{"issue":"1","key":"3569_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01260-0","volume":"15","author":"M Liao","year":"2022","unstructured":"Liao M, Qin R, Huang W, Zhu HP, Peng F, Han B, et al. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies. J Hematol Oncol. 2022;15(1):44.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3569_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00261-5","volume":"7","author":"Z Yin","year":"2021","unstructured":"Yin Z, Chen W, Yin J, Sun J, Xie Q, Wu M, et al. RIPK1 is a negative mediator in Aquaporin 1-driven triple-negative breast carcinoma progression and metastasis. NPJ Breast Cancer. 2021;7(1):53.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"3569_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010085","volume":"20","author":"P Masso-Welch","year":"2018","unstructured":"Masso-Welch P, Girald Berlingeri S, King-Lyons ND, Mandell L, Hu J, Greene CJ, et al. LT-IIc, A bacterial type II Heat-Labile Enterotoxin, induces specific lethality in triple negative breast cancer cells by modulation of autophagy and induction of apoptosis and necroptosis. Int J Mol Sci. 2018;20(1):85.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3569_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57282-1","volume":"10","author":"J Mann","year":"2020","unstructured":"Mann J, Yang N, Montpetit R, Kirschenman R, Lemieux H, Goping IS. BAD sensitizes breast cancer cells to docetaxel with increased mitotic arrest and necroptosis. Sci Rep. 2020;10(1):355.","journal-title":"Sci Rep"},{"key":"3569_CR125","doi-asserted-by":"crossref","unstructured":"Ryu HS. Tyrosine aminoacyl-tRNA synthetase sensitizes breast cancer to chemotherapy througha necroptosis-mediated mechanism: High-throughput proteomics and machine learningalgorithm based feature selection analyses. Cancer Res. 2020;80(4_Supplement):P1-10-19-P1-10-9.","DOI":"10.1158\/1538-7445.SABCS19-P1-10-19"},{"issue":"13","key":"3569_CR126","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.2174\/1871520622666220118093643","volume":"22","author":"Yping Liu","year":"2022","unstructured":"Liu Yping, Lei J, Yin MM, Chen Y. Organoantimony (III) derivative induces necroptosis in human breast cancer MDA-MB-231 cells. Anti-Cancer Agents in Medicinal Chemistry. 2022;22(13):2448\u201357.","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"key":"3569_CR127","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer. Annu Rev Pathol. 2022;17:181\u2013204.","journal-title":"Annu Rev Pathol"},{"issue":"25","key":"3569_CR128","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1016\/j.cell.2024.09.032","volume":"187","author":"L Xu","year":"2024","unstructured":"Xu L, Peng F, Luo Q, Ding Y, Yuan F, Zheng L, et al. IRE1\u03b1 silences DsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer. Cell. 2024;187(25):7248\u2013e726634.","journal-title":"Cell"},{"issue":"1","key":"3569_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51980-9","volume":"15","author":"B Ouyang","year":"2024","unstructured":"Ouyang B, Shan C, Shen S, Dai X, Chen Q, Su X, et al. AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer. Nat Commun. 2024;15(1):7560.","journal-title":"Nat Commun"},{"issue":"1","key":"3569_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02727-7","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Y, Ji DK, Huang Y, Huang W, Dong X, et al. Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer. J Nanobiotechnol. 2024;22(1):461.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"3569_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03454-9","volume":"12","author":"H An","year":"2021","unstructured":"An H, Heo JS, Kim P, Lian Z, Lee S, Park J, et al. Tetraarsenic hexoxide enhances generation of mitochondrial ROS to promote pyroptosis by inducing the activation of caspase-3\/GSDME in triple-negative breast cancer cells. Cell Death Dis. 2021;12(2):159.","journal-title":"Cell Death Dis"},{"issue":"7","key":"3569_CR132","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.7150\/ijbs.68438","volume":"18","author":"J Xia","year":"2022","unstructured":"Xia J, Chu C, Li W, Chen H, Xie W, Cheng R, et al. Mitochondrial protein UCP1 inhibits the malignant behaviors of triple-negative breast cancer through activation of mitophagy and pyroptosis. Int J Biol Sci. 2022;18(7):2949\u201361.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"3569_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123221","volume":"15","author":"L Wu","year":"2023","unstructured":"Wu L, Bai S, Huang J, Cui G, Li Q, Wang J, et al. Nigericin boosts anti-tumor immune response via inducing pyroptosis in Triple-Negative breast cancer. Cancers (Basel). 2023;15(12):3221.","journal-title":"Cancers (Basel)"},{"issue":"13","key":"3569_CR134","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.1021\/acs.jmedchem.3c00118","volume":"66","author":"R Sang","year":"2023","unstructured":"Sang R, Fan R, Deng A, Gou J, Lin R, Zhao T, et al. Degradation of hexokinase 2 blocks glycolysis and induces GSDME-dependent pyroptosis to amplify immunogenic cell death for breast cancer therapy. J Med Chem. 2023;66(13):8464\u201383.","journal-title":"J Med Chem"},{"issue":"42","key":"3569_CR135","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.2174\/0113816128268130231026054649","volume":"29","author":"Y Jin","year":"2023","unstructured":"Jin Y, Zhai M, Cao R, Yu H, Wu C, Liu Y. Silencing MFHAS1 induces pyroptosis via the JNK-activated NF-\u03baB\/caspase1\/GSDMD signal axis in breast cancer. Curr Pharm Des. 2023;29(42):3408\u201320.","journal-title":"Curr Pharm Des"},{"key":"3569_CR136","doi-asserted-by":"crossref","unstructured":"Chen Xyu, Liu Y, Zhu W, bo, Li S hao, Wei S, Cai J et al. Arming oncolytic M1 virus with gasdermin E enhances antitumor efficacy in breast cancer. iScience. 2024;27(11):111148.","DOI":"10.1016\/j.isci.2024.111148"},{"issue":"19","key":"3569_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910509","volume":"25","author":"T Pan","year":"2024","unstructured":"Pan T, Peng L, Dong J, Li L. Pterostilbene induces pyroptosis in breast cancer cells through pyruvate kinase 2\/Caspase-8\/Gasdermin C signaling pathway. Int J Mol Sci. 2024;25(19):10509.","journal-title":"Int J Mol Sci"},{"issue":"7725","key":"3569_CR138","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41586-018-0519-y","volume":"562","author":"M Seehawer","year":"2018","unstructured":"Seehawer M, Heinzmann F, D\u2019Artista L, Harbig J, Roux PF, Hoenicke L, et al. Necroptosis microenvironment directs lineage commitment in liver cancer. Nature. 2018;562(7725):69\u201375.","journal-title":"Nature"},{"issue":"5","key":"3569_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2509-x","volume":"11","author":"G Wang","year":"2020","unstructured":"Wang G, Wang Q, Liang N, Xue H, Yang T, Chen X, et al. Oncogenic driver genes and tumor microenvironment determine the type of liver cancer. Cell Death Dis. 2020;11(5):313.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3569_CR140","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ccell.2016.11.009","volume":"31","author":"AT Schneider","year":"2017","unstructured":"Schneider AT, Gautheron J, Feoktistova M, Roderburg C, Loosen SH, Roy S, et al. RIPK1 suppresses a TRAF2-Dependent pathway to liver cancer. Cancer Cell. 2017;31(1):94\u2013109.","journal-title":"Cancer Cell"},{"issue":"11","key":"3569_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.362","volume":"7","author":"A Filliol","year":"2016","unstructured":"Filliol A, Piquet-Pellorce C, Le Seyec J, Farooq M, Genet V, Lucas-Clerc C, et al. RIPK1 protects from TNF-\u03b1-mediated liver damage during hepatitis. Cell Death Dis. 2016;7(11):e2462.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3569_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1277-3","volume":"10","author":"M Farooq","year":"2019","unstructured":"Farooq M, Filliol A, Simoes Eug\u00e9nio M, Piquet-Pellorce C, Dion S, Raguenes-Nicol C, et al. Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis. Cell Death Dis. 2019;10(1):12.","journal-title":"Cell Death Dis"},{"issue":"7","key":"3569_CR143","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.immuni.2023.05.017","volume":"56","author":"M Vucur","year":"2023","unstructured":"Vucur M, Ghallab A, Schneider AT, Adili A, Cheng M, Castoldi M, et al. Sublethal necroptosis signaling promotes inflammation and liver cancer. Immunity. 2023;56(7):1578\u2013e15958.","journal-title":"Immunity"},{"key":"3569_CR144","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0168-8278(22)00442-1","volume":"77","author":"M Vucur","year":"2022","unstructured":"Vucur M, Ghallab A, Schneider A, Kather J, Govaere O, Villanueva A, et al. LB003 - Reprogramming necroptosis limits immune responses and prevents liver cancer development. J Hepatol. 2022;77:S11\u20132.","journal-title":"J Hepatol"},{"key":"3569_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120594","volume":"301","author":"SM El-Demiry","year":"2022","unstructured":"El-Demiry SM, El-Yamany M, El-Gendy SM, Salem HA, Saber MM. Necroptosis modulation by cisplatin and sunitinib in hepatocellular carcinoma cell line. Life Sci. 2022;301:120594.","journal-title":"Life Sci"},{"issue":"14","key":"3569_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16142533","volume":"16","author":"R Kong","year":"2024","unstructured":"Kong R, Wang N, Zhou C, Zhou Y, Guo X, Wang D, et al. Sanguinarine induces necroptosis of HCC by targeting PKM2 mediated energy metabolism. Cancers. 2024;16(14):2533.","journal-title":"Cancers"},{"issue":"2","key":"3569_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020447","volume":"14","author":"J Wang","year":"2022","unstructured":"Wang J, Wang Y, Steffani M, St\u00f6\u00df C, Ankerst D, Friess H, et al. Novel risk classification based on pyroptosis-related genes defines immune microenvironment and pharmaceutical landscape for hepatocellular carcinoma. Cancers. 2022;14(2):447.","journal-title":"Cancers"},{"issue":"1","key":"3569_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02354-2","volume":"22","author":"Q Du","year":"2024","unstructured":"Du Q, Luo Y, Xu L, Du C, Zhang W, Xu J, et al. Smart responsive Fe\/Mn nanovaccine triggers liver cancer immunotherapy via pyroptosis and pyroptosis-boosted cGAS-STING activation. J Nanobiotechnol. 2024;22(1):95.","journal-title":"J Nanobiotechnol"},{"key":"3569_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1433126","volume":"12","author":"Y Huang","year":"2024","unstructured":"Huang Y, Li Y, He R, Dong S, Zhao Z, Jiao X. Cancer immunogenic cell death via pyroptosis with CXCR4-targeted nanotoxins in hepatocellular carcinoma. Front Bioeng Biotechnol. 2024;12:1433126.","journal-title":"Front Bioeng Biotechnol"},{"issue":"7","key":"3569_CR150","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302606","volume":"13","author":"N Zhang","year":"2024","unstructured":"Zhang N, Zeng W, Xu Y, Li R, Wang M, Liu Y, et al. Pyroptosis induction with nanosonosensitizer-augmented sonodynamic therapy combined with PD-L1 blockade boosts efficacy against liver cancer. Adv Healthc Mater. 2024;13(7):2302606.","journal-title":"Adv Healthc Mater"},{"key":"3569_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.697832","volume":"9","author":"F Shangguan","year":"2021","unstructured":"Shangguan F, Zhou H, Ma N, Wu S, Huang H, Jin G, et al. A novel mechanism of Cannabidiol in suppressing hepatocellular carcinoma by inducing GSDME dependent pyroptosis. Front Cell Dev Biol. 2021;9:697832.","journal-title":"Front Cell Dev Biol"},{"key":"3569_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217183","volume":"601","author":"L Cui","year":"2024","unstructured":"Cui L, Xu X, Fan H, Wan X, Chen Q, Zhang J, et al. Reuterin promotes pyroptosis in hepatocellular cancer cells through mtDNA-mediated STING activation and caspase 8 expression. Cancer Lett. 2024;601:217183.","journal-title":"Cancer Lett"},{"issue":"1","key":"3569_CR153","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5596","volume":"64","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Yang S, Dai W, Wang J, Bi S, Zhang X, et al. CHMP3 promotes the progression of hepatocellular carcinoma by inhibiting caspase\u20131\u2013dependent pyroptosis. Int J Oncol. 2023;64(1):8.","journal-title":"Int J Oncol"},{"issue":"1","key":"3569_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02285-9","volume":"11","author":"Z Liao","year":"2025","unstructured":"Liao Z, Yang L, Cheng X, Huang X, Zhang Q, Wen D, et al. Pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation. Cell Death Discov. 2025;11(1):11.","journal-title":"Cell Death Discov"},{"key":"3569_CR155","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.812655","volume":"12","author":"Z Yan","year":"2022","unstructured":"Yan Z, Da Q, Li Z, Lin Q, Yi J, Su Y, et al. Inhibition of NEK7 suppressed hepatocellular carcinoma progression by mediating cancer cell pyroptosis. Front Oncol. 2022;12:812655.","journal-title":"Front Oncol"},{"issue":"14","key":"3569_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143579","volume":"13","author":"M Berehab","year":"2021","unstructured":"Berehab M, Rouas R, Akl H, Duvillier H, Journe F, Fayyad-Kazan H, et al. Apoptotic and non-apoptotic modalities of Thymoquinone-induced lymphoma cell death: highlight of the role of cytosolic calcium and necroptosis. Cancers. 2021;13(14):3579.","journal-title":"Cancers"},{"issue":"7","key":"3569_CR157","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1158\/1535-7163.MCT-17-0848","volume":"17","author":"GA Ward","year":"2018","unstructured":"Ward GA, Lewis EJ, Ahn JS, Johnson CN, Lyons JF, Martins V, et al. ASTX660, a novel non-peptidomimetic antagonist of cIAP1\/2 and XIAP, potently induces TNF\u03b1-dependent apoptosis in cancer cell lines and inhibits tumor growth. Mol Cancer Ther. 2018;17(7):1381\u201391.","journal-title":"Mol Cancer Ther"},{"issue":"Supplement 1","key":"3569_CR158","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1182\/blood-2021-152176","volume":"138","author":"GA Ward","year":"2021","unstructured":"Ward GA, Jueliger S, Sims M, Davis M, Boxall A, Saini H, et al. Combining the IAP antagonist Tolinapant with a DNA hypomethylating agent enhances immunogenic cell death in preclinical models of T-cell lymphoma. Blood. 2021;138(Supplement 1):3986\u20133986.","journal-title":"Blood"},{"issue":"6","key":"3569_CR159","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1158\/2767-9764.CRC-23-0415","volume":"4","author":"GA Ward","year":"2024","unstructured":"Ward GA, Zhang Z, Jueliger S, Potapov IS, Davis MP, Boxall AR, et al. Epigenetic priming by hypomethylation enhances the immunogenic potential of Tolinapant in T-cell lymphoma. Cancer Res Commun. 2024;4(6):1441\u201353.","journal-title":"Cancer Res Commun"},{"issue":"Supplement 1","key":"3569_CR160","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1182\/blood-2023-186712","volume":"142","author":"G Ward","year":"2023","unstructured":"Ward G, Zhang Z, Jueliger S, Potapov I, Davis MP, Boxall A, et al. Epigenetic priming by hypomethylation enhances the immunogenic potential of Tolinapant in T-cell lymphoma. Blood. 2023;142(Supplement 1):1439\u20131439.","journal-title":"Blood"},{"key":"3569_CR161","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.canlet.2020.12.015","volume":"500","author":"N Casagrande","year":"2021","unstructured":"Casagrande N, Borghese C, Favero A, Vicenzetto C, Aldinucci D. Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in hodgkin lymphoma. Cancer Lett. 2021;500:182\u201393.","journal-title":"Cancer Lett"},{"issue":"7","key":"3569_CR162","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1111\/cas.16180","volume":"115","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li L, Zhang Z, Gao S, Yang M, Ma W, et al. Pyroptotic macrophages promote proliferation and chemotherapy resistance of peripheral T-cell lymphoma via TLR4 signaling pathway. Cancer Sci. 2024;115(7):2444\u201360.","journal-title":"Cancer Sci"},{"key":"3569_CR163","doi-asserted-by":"crossref","unstructured":"Li X, Liu B, Huang D, Ma N, Xia J, Zhao X, et al. Chidamide triggers pyroptosis in T-cell lymphoblastic lymphoma\/leukemia via the FOXO1\/GSDME axis. Chin Med J. 2024;138(10):1213\u201324.","DOI":"10.1097\/CM9.0000000000003214"},{"issue":"Supplement 1","key":"3569_CR164","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1182\/blood-2021-147268","volume":"138","author":"Y Cai","year":"2021","unstructured":"Cai Y, Zhou X, Hu S, Lu T, Chen X, Ding M, et al. SAMHD1 performs tumor-promoting effects in diffuse large B-cell lymphoma by inhibiting DNA damage and sting-mediated cell pyroptosis. Blood. 2021;138(Supplement 1):869\u2013869.","journal-title":"Blood"},{"issue":"19","key":"3569_CR165","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1182\/blood.2023022241","volume":"143","author":"MH Abdelrazak Morsy","year":"2024","unstructured":"Abdelrazak Morsy MH, Lilienthal I, Lord M, Merrien M, Wasik AM, Sureda-G\u00f3mez M, et al. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood. 2024;143(19):1953\u201364.","journal-title":"Blood"},{"issue":"3\u20134","key":"3569_CR166","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10495-019-01589-x","volume":"25","author":"X Xia","year":"2020","unstructured":"Xia X, Lei L, Wang S, Hu J, Zhang G. Necroptosis and its role in infectious diseases. Apoptosis. 2020;25(3\u20134):169\u201378.","journal-title":"Apoptosis"},{"issue":"8","key":"3569_CR167","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.biopha.2013.06.002","volume":"67","author":"M Wu","year":"2013","unstructured":"Wu M, Jiang Z, Duan H, Sun L, Zhang S, Chen M, et al. Deoxypodophyllotoxin triggers necroptosis in human non-small cell lung cancer NCI-H460 cells. Biomed Pharmacother. 2013;67(8):701\u20136.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3569_CR168","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02568-4","volume":"22","author":"M Wang","year":"2024","unstructured":"Wang M, Cai R, Zhang Z, Feng L, Lei Z, Wang F, et al. NIR-responsive CN-Pt-GEM hydrogel induces necroptosis and immunotherapeutic responses prevent postoperative recurrence and wound infection in lung carcinoma. J Nanobiotechnol. 2024;22(1):355.","journal-title":"J Nanobiotechnol"},{"key":"3569_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116852","volume":"236","author":"H Hao","year":"2025","unstructured":"Hao H, Tian W, Gong J, Li J, Zhou S, Guo Z, et al. Targeting the CXCR7 pathway with TC14012 to inhibit endothelial necroptosis and lung cancer metastasis. Biochem Pharmacol. 2025;236:116852.","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"3569_CR170","doi-asserted-by":"publisher","DOI":"10.3892\/or.2025.8889","volume":"53","author":"Y Hu","year":"2025","unstructured":"Hu Y, Liu X, Yuan Z, He J, Ma R, Wang Y, et al. Induction of necroptosis in lung adenocarcinoma by miR\u201310b\u20135p through modulation of the PKP3\/RIPK3\/MLKL cascade. Oncol Rep. 2025;53(5):56.","journal-title":"Oncol Rep"},{"issue":"1","key":"3569_CR171","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05166-6","volume":"6","author":"H Zhou","year":"2023","unstructured":"Zhou H, Zhou L, Guan Q, Hou X, Wang C, Liu L, et al. Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells. Commun Biol. 2023;6(1):805.","journal-title":"Commun Biol"},{"issue":"3","key":"3569_CR172","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2025.5727","volume":"66","author":"Y Xi","year":"2025","unstructured":"Xi Y, Zeng S, Tan X, Deng X. Curcumin inhibits the activity of ubiquitin ligase Smurf2 to promote NLRP3\u2013dependent pyroptosis in non\u2013small cell lung cancer cells. Int J Oncol. 2025;66(3):21.","journal-title":"Int J Oncol"},{"key":"3569_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113703","volume":"144","author":"D Chen","year":"2025","unstructured":"Chen D, Ji H, Wang D, Xu Y, Yang F, Hu W, et al. Transcription factor MAFK binds to circrpph to regulate SIRT gene-mediated cellular pyroptosis and lung adenocarcinoma progression. Int Immunopharmacol. 2025;144:113703.","journal-title":"Int Immunopharmacol"},{"key":"3569_CR174","doi-asserted-by":"crossref","unstructured":"Li H, Zhang J, Yu B, Yang T, Liu B, Li F, et al. Rspo3 regulates the radioresistance of non-small cell lung cancer cells via Nlrp3 inflammasome-mediated pyroptosis. Radiother Oncol. 2024;200.","DOI":"10.1016\/j.radonc.2024.110528"},{"key":"3569_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111083","volume":"397","author":"C Xie","year":"2024","unstructured":"Xie C, Zhou X, Chen W, Ren D, Li X, Jiang R, et al. Diallyl trisulfide induces pyroptosis and impairs lung CSC-like properties by activating the ROS\/caspase 1 signaling pathway. Chem Biol Interact. 2024;397:111083.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"3569_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53629-z","volume":"15","author":"AE Culver-Cochran","year":"2024","unstructured":"Culver-Cochran AE, Hassan A, Hueneman K, Choi K, Ma A, VanCauwenbergh B, et al. Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosis. Nat Commun. 2024;15(1):9189.","journal-title":"Nat Commun"},{"issue":"16","key":"3569_CR177","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi1782","volume":"10","author":"S Zhu","year":"2024","unstructured":"Zhu S, Luo Y, Li K, Mei C, Wang Y, Jiang L, et al. RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells. Sci Adv. 2024;10(16):eadi1782.","journal-title":"Sci Adv"},{"key":"3569_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123091","volume":"317","author":"F Jin","year":"2025","unstructured":"Jin F, Wei X, Liu Y, Tang L, Ren J, Yang J, et al. Engineered cell membrane vesicles loaded with lysosomophilic drug for acute myeloid leukemia therapy via organ-cell-organelle cascade-targeting. Biomaterials. 2025;317:123091.","journal-title":"Biomaterials"},{"issue":"5","key":"3569_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26051323","volume":"26","author":"J Mondet","year":"2021","unstructured":"Mondet J, Chevalier S, Mossuz P. Pathogenic roles of S100A8 and S100A9 proteins in acute myeloid and lymphoid leukemia: clinical and therapeutic impacts. Molecules. 2021;26(5):1323.","journal-title":"Molecules"},{"issue":"3","key":"3569_CR180","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00277-023-05103-x","volume":"102","author":"S Mao","year":"2023","unstructured":"Mao S, Qian Y, Wei W, Lin X, Ling Q, Ye W, et al. Flot1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis. Ann Hematol. 2023;102(3):583\u201395.","journal-title":"Ann Hematol"},{"issue":"24","key":"3569_CR181","doi-asserted-by":"publisher","first-page":"21795","DOI":"10.1021\/acs.jmedchem.4c01354","volume":"67","author":"X Yu","year":"2024","unstructured":"Yu X, Zhou Y, Ma X, Zhang W, Li F, Jiang F, et al. Erlotinib-Gold(I) complex induces leukemia cell DC differentiation and remodels the immunosuppressive microenvironment. J Med Chem. 2024;67(24):21795\u2013810.","journal-title":"J Med Chem"},{"issue":"1","key":"3569_CR182","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41375-024-02437-x","volume":"39","author":"C Yang","year":"2025","unstructured":"Yang C, Hu Y, Gao L, Li Z, Zhang Y, Zhuo R, et al. Anagrelide and idarubicin combination induces GSDME-mediated pyroptosis as a potential therapy for high-PDE3A acute myeloid leukemia. Leukemia. 2025;39(1):98\u2013111.","journal-title":"Leukemia"},{"issue":"1","key":"3569_CR183","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03335-9","volume":"23","author":"Z Yuan","year":"2025","unstructured":"Yuan Z, Jiang G, Yuan Y, Liang Q, Hou Y, Zhang W, et al. 5-FU@HFn combined with decitabine induces pyroptosis and enhances antitumor immunotherapy for chronic myeloid leukemia. J Nanobiotechnol. 2025;23(1):252.","journal-title":"J Nanobiotechnol"},{"key":"3569_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216797","volume":"588","author":"Y He","year":"2024","unstructured":"He Y, Jiang S, Cui Y, Liang J, Zhong Y, Sun Y, et al. Induction of IFIT1\/IFIT3 and inhibition of Bcl-2 orchestrate the treatment of myeloma and leukemia via pyroptosis. Cancer Lett. 2024;588:216797.","journal-title":"Cancer Lett"},{"key":"3569_CR185","doi-asserted-by":"publisher","first-page":"105945","DOI":"10.1016\/j.tiv.2024.105945","volume":"101","author":"I Mota","year":"2024","unstructured":"Mota I, de Cardoso S, Bueno M, da Silva J, Gon\u00e7alves IGM, Bao J. Intragenic antimicrobial peptide Hs02 toxicity against leukemia cell lines is associated with increased expression of select pyroptotic components. Toxicol Vitro. 2024;101:105945.","journal-title":"Toxicol Vitro"},{"issue":"7914","key":"3569_CR186","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-022-04753-7","volume":"606","author":"T Zhang","year":"2022","unstructured":"Zhang T, Yin C, Fedorov A, Qiao L, Bao H, Beknazarov N, et al. ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis. Nature. 2022;606(7914):594\u2013602.","journal-title":"Nature"},{"issue":"10","key":"3569_CR187","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19102975","volume":"19","author":"Q Kong","year":"2018","unstructured":"Kong Q, Lv J, Yan S, Chang KJ, Wang GA. Novel naphthyridine. Derivative, 3u, induces necroptosis at low concentrations and apoptosis at high concentrations in human melanoma A375 cells. Int J Mol Sci. 2018;19(10):2975.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3569_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/foods9101486","volume":"9","author":"V Nanni","year":"2020","unstructured":"Nanni V, Di Marco G, Sacchetti G, Canini A, Gismondi A. Oregano phytocomplex induces programmed cell death in melanoma lines via mitochondria and DNA damage. Foods. 2020;9(10):1486.","journal-title":"Foods"},{"issue":"10","key":"3569_CR189","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1488359","volume":"7","author":"L Sun","year":"2018","unstructured":"Sun L, Moore E, Berman R, Clavijo PE, Saleh A, Chen Z, et al. Wee1 kinase inhibition reverses G2\/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy. Oncoimmunology. 2018;7(10):e1488359.","journal-title":"Oncoimmunology"},{"issue":"1","key":"3569_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05979-8","volume":"9","author":"L Van Hoecke","year":"2018","unstructured":"Van Hoecke L, Van Lint S, Roose K, Van Parys A, Vandenabeele P, Grooten J, et al. Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes. Nat Commun. 2018;9(1):3417.","journal-title":"Nat Commun"},{"issue":"1","key":"3569_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02146-0","volume":"21","author":"S Wang","year":"2023","unstructured":"Wang S, Guo Q, Xu R, Lin P, Deng G, Xia X. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of melanoma. J Nanobiotechnol. 2023;21(1):383.","journal-title":"J Nanobiotechnol"},{"issue":"12","key":"3569_CR192","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1038\/s41401-024-01349-x","volume":"45","author":"ZM Wang","year":"2024","unstructured":"Wang ZM, Li MK, Yang QL, Duan SX, Lou XY, Yang XY, et al. Recombinant human adenovirus type 5 promotes anti-tumor immunity via inducing pyroptosis in tumor endothelial cells. Acta Pharmacol Sin. 2024;45(12):2646\u201356.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"3569_CR193","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2024.5420","volume":"54","author":"X Jiu","year":"2024","unstructured":"Jiu X, Li W, Liu Y, Liu L, Lu H. TREM2, a critical activator of pyroptosis, mediates the anti\u2013tumor effects of Piceatannol in uveal melanoma cells via caspase 3\/GSDME pathway. Int J Mol Med. 2024;54(5):96.","journal-title":"Int J Mol Med"},{"issue":"1","key":"3569_CR194","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01784-7","volume":"22","author":"W Wu","year":"2024","unstructured":"Wu W, Wu MY, Dai T, Ke LN, Shi Y, Hu J, et al. Terphenyllin induces CASP3-dependent apoptosis and pyroptosis in A375 cells through upregulation of p53. Cell Commun Signal. 2024;22(1):409.","journal-title":"Cell Commun Signal"},{"issue":"31","key":"3569_CR195","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404375","volume":"11","author":"H Ren","year":"2024","unstructured":"Ren H, Wu Z, Tan J, Tao H, Zou W, Cao Z, et al. Co-delivery nano system of MS-275 and V-9302 induces pyroptosis and enhances anti-tumor immunity against uveal melanoma. Adv Sci. 2024;11(31):2404375.","journal-title":"Adv Sci"},{"issue":"6","key":"3569_CR196","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1039\/D2BM02026B","volume":"11","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Huang Y, Wang J, Lin H, Cao F, Li S, et al. A self-assembling CXCR4-targeted pyroptosis nanotoxin for melanoma therapy. Biomater Sci. 2023;11(6):2200\u201310.","journal-title":"Biomater Sci"},{"issue":"7","key":"3569_CR197","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1039\/D2CC05498A","volume":"59","author":"MJ Zhang","year":"2023","unstructured":"Zhang MJ, Liang MY, Yang SC, Ma XB, Wan SC, Yang QC, et al. Bioengineering of BRAF and COX2 inhibitor nanogels to boost the immunotherapy of melanoma via pyroptosis. Chem Commun. 2023;59(7):932\u20135.","journal-title":"Chem Commun"},{"key":"3569_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123108","volume":"358","author":"B Zhou","year":"2024","unstructured":"Zhou B, Qin Q, Fang Y, Liu X, Zhang M, Wang S, et al. Exosomes from human bone marrow MSCs alleviate PD-1\/PD-L1 inhibitor-induced myocardial injury in melanoma mice by regulating macrophage polarization and pyroptosis. Life Sci. 2024;358:123108.","journal-title":"Life Sci"},{"key":"3569_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106660","volume":"188","author":"B Zeng","year":"2023","unstructured":"Zeng B, Chen Y, Chen H, Zhao Q, Sun Z, Liu D, et al. Exosomal miR-211-5p regulates glucose metabolism, pyroptosis, and immune microenvironment of melanoma through GNA15. Pharmacol Res. 2023;188:106660.","journal-title":"Pharmacol Res"},{"key":"3569_CR200","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120832","volume":"307","author":"J Zhong","year":"2022","unstructured":"Zhong J, Wang Z, Houssou Hounye A, Liu J, Zhang J, Qi M. A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma. Life Sci. 2022;307:120832.","journal-title":"Life Sci"},{"issue":"1","key":"3569_CR201","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03245-y","volume":"43","author":"Y He","year":"2024","unstructured":"He Y, Wang J, Deng Z, Feng H, Du M, Zhang D, et al. FOLR2\u2009+\u2009macrophage depletion from intestinal metaplasia to early gastric cancer: single-cell sequencing insight into gastric cancer progression. J Exp Clin Cancer Res. 2024;43(1):326.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"3569_CR202","doi-asserted-by":"publisher","DOI":"10.3390\/genes16030341","volume":"16","author":"K Medhi","year":"2025","unstructured":"Medhi K, Mukherjee S, Dagar A, Tiwari AK, Daffara S, Bana S, et al. MYOSLID: a critical modulator of cancer hallmarks. Genes. 2025;16(3):341.","journal-title":"Genes"},{"key":"3569_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107937","volume":"153","author":"X Liu","year":"2024","unstructured":"Liu X, Jin Y, Zhang M, Jin Y, Cao J, Dong H, et al. The RIP3 activator C8 regulates the autophagy flux mediated by p62 and promotes the immunogenic form of cell death in human gastric cancer cells. Bioorg Chem. 2024;153:107937.","journal-title":"Bioorg Chem"},{"issue":"1","key":"3569_CR204","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01161-8","volume":"8","author":"H Wang","year":"2022","unstructured":"Wang H, Liu M, Zeng X, Zheng Y, Wang Y, Zhou Y. Cell death affecting the progression of gastric cancer. Cell Death Discov. 2022;8(1):377.","journal-title":"Cell Death Discov"},{"issue":"30","key":"3569_CR205","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303908","volume":"10","author":"W Lin","year":"2023","unstructured":"Lin W, Zhang Y, Yang Y, Lin B, Zhu M, Xu J, et al. Anti-PD-1\/Her2 bispecific antibody IBI315 enhances the treatment effect of Her2-Positive gastric cancer through gasdermin B-cleavage induced pyroptosis. Adv Sci. 2023;10(30):e2303908.","journal-title":"Adv Sci"},{"issue":"4","key":"3569_CR206","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41401-024-01414-5","volume":"46","author":"QY Luo","year":"2025","unstructured":"Luo QY, Yang J, Di T, Xia ZF, Zhang L, Pan WT, et al. The novel BCL-2\/BCL-XL inhibitor APG-1252-mediated cleavage of GSDME enhances the antitumor efficacy of HER2-targeted therapy in HER2-positive gastric cancer. Acta Pharmacol Sin. 2025;46(4):1082\u201396.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"3569_CR207","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06832-1","volume":"15","author":"X Jiang","year":"2024","unstructured":"Jiang X, Zhu Z, Ding L, Du W, Pei D. ALKBH4 impedes 5-FU sensitivity through suppressing GSDME induced pyroptosis in gastric cancer. Cell Death Dis. 2024;15(6):435.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3569_CR208","doi-asserted-by":"publisher","first-page":"346","DOI":"10.7150\/ijbs.97464","volume":"21","author":"S Wang","year":"2025","unstructured":"Wang S, Xuan Z, Chen Z, Xu P, Fang L, Li Z, et al. Helicobacter pylori-induced BRD2 m6A modification sensitizes gastric cancer cells to chemotherapy by breaking FLIP\/Caspase-8 homeostasis. Int J Biol Sci. 2025;21(1):346\u201362.","journal-title":"Int J Biol Sci"},{"key":"3569_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2025.128142","volume":"296","author":"S Xiao","year":"2025","unstructured":"Xiao S, Shen Y, Zhang M, Liu X, Cai T, Wang F. VacA promotes pyroptosis via TNFAIP3\/TRAF1 signaling to induce onset of atrophic gastritis. Microbiol Res. 2025;296:128142.","journal-title":"Microbiol Res"},{"issue":"1","key":"3569_CR210","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/imr.13294","volume":"321","author":"Z Guo","year":"2024","unstructured":"Guo Z, Su Z, Wei Y, Zhang X, Hong X. Pyroptosis in glioma: current management and future application. Immunol Rev. 2024;321(1):152\u201368.","journal-title":"Immunol Rev"},{"key":"3569_CR211","doi-asserted-by":"crossref","unstructured":"Yang H, Jiang B, Li W, Du G, Xu F, Zhang Y, et al. 7 I, a structurally modified sinomenine, exerts dual anti-GBM effects by inhibiting glioblastoma proliferation and inducing necroptosis which further mediates lysosomal cell death. Br J Pharmacol. 2025;182(10):2310\u201331.","DOI":"10.1111\/bph.17464"},{"issue":"1","key":"3569_CR212","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01731-z","volume":"20","author":"P Zhao","year":"2022","unstructured":"Zhao P, Tian Y, Lu Y, Zhang J, Tao A, Xiang G, et al. Biomimetic calcium carbonate nanoparticles delivered IL-12 mRNA for targeted glioblastoma sono-immunotherapy by ultrasound-induced necroptosis. J Nanobiotechnol. 2022;20(1):525.","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"3569_CR213","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06654-1","volume":"15","author":"H Damhofer","year":"2024","unstructured":"Damhofer H, Tatar T, Southgate B, Scarneo S, Agger K, Shlyueva D, et al. TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers. Cell Death Dis. 2024;15(4):273.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3569_CR214","doi-asserted-by":"publisher","DOI":"10.3892\/or.2025.8873","volume":"53","author":"D Lv","year":"2025","unstructured":"Lv D, Han X, Hao L, Sun Z, Zhang A, Liu J, et al. Cysteine\u2013 and glycine\u2013rich protein 2: a vital regulator that inhibits necroptosis glioma cell by activating the JAK\u2013STAT1 pathways. Oncol Rep. 2025;53(3):40.","journal-title":"Oncol Rep"},{"issue":"1","key":"3569_CR215","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03091-w","volume":"23","author":"X Hao","year":"2025","unstructured":"Hao X, Tang Y, Xu W, Wang M, Liu J, Li Y, et al. Engineered biomimetic cisplatin-polyphenol nanocomplex for chemo-immunotherapy of glioblastoma by inducing pyroptosis. J Nanobiotechnol. 2025;23(1):14.","journal-title":"J Nanobiotechnol"},{"issue":"788","key":"3569_CR216","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ado0020","volume":"17","author":"S Sun","year":"2025","unstructured":"Sun S, Qian S, Wang R, Zhao M, Li R, Gu W, et al. Targeting GOLPH3L improves glioblastoma radiotherapy by regulating STING-NLRP3-mediated tumor immune microenvironment reprogramming. Sci Transl Med. 2025;17(788):eado0020.","journal-title":"Sci Transl Med"},{"key":"3569_CR217","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.123035","volume":"317","author":"X Gao","year":"2025","unstructured":"Gao X, Tang X, Tu Z, Yu J, Bao Y, Long G, et al. Tertiary amine modification enables triterpene nanoparticles to target the mitochondria and treat glioblastoma via pyroptosis induction. Biomaterials. 2025;317:123035.","journal-title":"Biomaterials"},{"issue":"1","key":"3569_CR218","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48606-5","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xi K, Fu Z, Zhang Y, Cheng B, Feng F, et al. Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse. Nat Commun. 2024;15(1):4241.","journal-title":"Nat Commun"},{"issue":"3","key":"3569_CR219","doi-asserted-by":"publisher","first-page":"e2403108","DOI":"10.1002\/adhm.202403108","volume":"14","author":"S Li","year":"2025","unstructured":"Li S, Zeng F, Zhou Q, Li L, Lo H, Chen J, et al. NIR-II photoacoustic Imaging-Guided Chemo-Photothermal therapy using PA1094T combined with Anti-CD47 antibody: activating pyroptosis against orthotopic glioblastoma. Adv Healthc Mater. 2025;14(3):e2403108.","journal-title":"Adv Healthc Mater"},{"issue":"4","key":"3569_CR220","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202400804","volume":"26","author":"Z Chen","year":"2025","unstructured":"Chen Z, Luo Y, Jia Q, Yang Z, Liu Z, Cui C, et al. Nir-II fluorescence imaging-guided photothermal activated pyroptosis for precision therapy of glioma. Chembiochem. 2025;26(4):e202400804.","journal-title":"Chembiochem"},{"issue":"5","key":"3569_CR221","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","volume":"24","author":"P Meier","year":"2024","unstructured":"Meier P, Legrand AJ, Adam D, Silke J. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat Rev Cancer. 2024;24(5):299\u2013315.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3569_CR222","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-02048-z","volume":"27","author":"J Munhoz","year":"2025","unstructured":"Munhoz J, Newell M, Goruk S, Ghosh S, Patel D, Joy AA, et al. Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial. Breast Cancer Res. 2025;27(1):91.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"3569_CR223","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0899-8","volume":"37","author":"X Ling","year":"2018","unstructured":"Ling X, Wu W, Fan C, Xu C, Liao J, Rich LJ, et al. An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. J Exp Clin Cancer Res. 2018;37(1):240.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"3569_CR224","first-page":"2267","volume":"8","author":"T Rabi","year":"2018","unstructured":"Rabi T, Li F. Multiple mechanisms involved in a low concentration of FL118 enhancement of AMR-MeOAc to induce pancreatic cancer cell apoptosis and growth inhibition. Am J Cancer Res. 2018;8(11):2267\u201383.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"3569_CR225","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.881","volume":"12","author":"X Ling","year":"2022","unstructured":"Ling X, Wu W, Aljahdali IAM, Liao J, Santha S, Fountzilas C, et al. FL118, acting as a molecular glue degrader, binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy. Clin Transl Med. 2022;12(5):e881.","journal-title":"Clin Transl Med"},{"issue":"3","key":"3569_CR226","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282244","volume":"18","author":"W Gong","year":"2023","unstructured":"Gong W, Fang P, Leng M, Shi Y. Promoting GSDME expression through DNA demethylation to increase chemosensitivity of breast cancer MCF-7 \/ Taxol cells. PLoS One. 2023;18(3):e0282244.","journal-title":"PLoS One"},{"key":"3569_CR227","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.796820","volume":"10","author":"Z Yu","year":"2022","unstructured":"Yu Z, Cao W, Han C, Wang Z, Qiu Y, Wang J, et al. Biomimetic metal-organic framework nanoparticles for synergistic combining of SDT-chemotherapy induce pyroptosis in gastric cancer. Front Bioeng Biotechnol. 2022;10:796820.","journal-title":"Front Bioeng Biotechnol"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03569-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03569-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03569-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:14:09Z","timestamp":1781615649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03569-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":227,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3569"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03569-3","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to the publication of the article in the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}